Equivalent price position
No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Erythromycin
- Therapeutic area
- Anti-infectives
- Drug class
- Macrolide antibacterials
- ATC
- J01FA
- Strength
- 4%
- Dosage form
- Lotion
- Pack
- 30ml
- Registration no.
- 054818
- Price record verified
- 2026-08-24
- Latest DRAP source check
- 2026-09-25 03:02
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 28.52 to 29.93 (+4.9%) between 22 Aug 2025 and 20 Aug 2026 · 2 official price records · pack 30ml
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. Ritocin 4%, 30ml: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/ritocin-4-054818-30ml-valor-pharmaceuticals/ (accessed 25 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 29.93 | 2026-08-20 | 2026-08-24 | DRAP PharmaPrice Index | Current |
| PKR 28.52 | 2025-08-22 | 2026-08-09 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 054818Price and registration data on this page were observed on 24 August 2026. Records change over time, so please cite the observation date alongside the access date.
